Prostate Cancer Clinical Trial
Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)
Summary
The EMPOWeR study is proposed as a cohort study with longitudinal follow-up to determine rates of genetic mutations among men with or at-risk for prostate cancer to address the various facets of genetic education and counseling for optimized genetic assessment and wellness of men. The results will inform practice guidelines and future studies for maximal impact of genetic evaluation of men for inherited prostate cancer.
Eligibility Criteria
Inclusion Criteria:
Men with a personal history of prostate cancer
Unaffected males who are at higher risk for prostate cancer (family history of prostate cancer or African American males)
Men who previously tested positive for a mutation may be eligible for Specific Aims 2-7
Men with a known familial mutation
Men who previously participated in the Genetic Evaluation of Men (GEM) study (IRB#14S.546) will be offered participation in EMPOWeR -
Exclusion Criteria:
Age < 18 years
Mental or cognitive impairment that interferes with ability to provide informed consent
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Philadelphia Pennsylvania, 19107, United States
How clear is this clinincal trial information?